Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia

Molica, M; Scalzulli, E; Colafigli, G; Foa, R; Breccia, M

Breccia, M (reprint author), Sapienza Univ, Haematol, Dept Cellular Biotechnol & Haematol, Azienda Osped,Policlin Umberto 1, Via Benevento 6, I-00161 Rome, Italy.

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019; 10 ():

Abstract

There are five tyrosine kinase inhibitors (TKIs) that are currently approved (in the European Union and the United States) for the treatment of chroni......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索